Wolfe Research downgraded Exact Sciences (EXAS) to Peer Perform from Outperform after Abbott (ABT) announced an agreement to acquire Exact for $105 per share in cash.
Claim 70% Off TipRanks Premium
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on EXAS: